Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10143945 | Journal of Global Antimicrobial Resistance | 2018 | 7 Pages |
Abstract
The prevalence of ceftriaxone-resistant SBP was significant at a US tertiary centre. Local epidemiological data and identification of risk factors associated with ceftriaxone-resistant SBP, e.g. increased usage of previous β-lactam therapy and invasive gastrointestinal procedure, may help clinicians identify patients requiring alternative empirical antibiotics.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Amelia K. Sofjan, Rachel J. Musgrove, Nicholas D. Beyda, Hannah P. Russo, Todd M. Lasco, Raymond Yau, Alejandro Restrepo, Kevin W. Garey,